section name header

Information ⬇

Editors

MiiraKlemetti-Pettersson
MarjaVääräsmäki

Overweight in Pregnancy

Essentials

  • Overweight and obesity, in particular, significantly increase risks to the pregnant woman, the fetus and the baby (e.g. fetal malformation, asphyxia, preterm delivery, post-term pregnancy, maternal gestational diabetes, pre-eclampsia, thromboembolic complications).
  • Treatment and support aimed at weight reduction should begin as early as possible, even before pregnancy. Lifestyle guidance should be started no later than early pregnancy.
  • If the body mass index (BMI) before pregnancy or in early pregnancy is HASH(0x2f82cc8) 40 kg/m2 , the woman can visit the maternity hospital around week 37 of pregnancy to plan the delivery, as considered necessary. Consulting an anaesthesiologist can also be considered.

Prevalence of overweight and related pregnancy risks

Treatment and follow-up before pregnancy

  • Favourable effects of weight loss on fertility Fertility Counselling and on reducing pregnancy and delivery complications should be discussed with overweight or obese women of fertile age (at visits related to weight management, family planning, childlessness or gynaecology, for instance).
  • Risks should be discussed with those planning pregnancy, and treatment and support aimed at weight reduction should be started as early as possible before pregnancy Conservative (Non-Surgical) Treatment of Obesity. See also article Motivational interviewing The Role of Motivational Interviewing in Changing Lifestyles and in Treatment.
  • Before stopping contraception, any medication that is forbidden during pregnancy (such as GLP-1 analogues used for weight reduction) should be withdrawn.
  • Folic acid supplementation (at least 400 µg/day) should be started as early as possible when planning pregnancy (no later than 2 months before stopping contraception).
  • For women who have undergone bariatric surgery, pregnancy is recommended only 1-2 years after surgery.
    • Before surgery, a discussion should be had with patients of fertile age to ensure that they are using reliable contraception (such as a hormonal IUD).
    • The aim should be to stabilize weight and to use appropriate dietary supplements regularly before stopping contraception.
    • See local guidance on dietary supplements.

Treatment and follow-up during pregnancy , Interventions for Preventing Excessive Weight Gain during Pregnancy, Association of Gestational Weight Gain with Maternal and Infant Outcomes, Diet and/or Exercise for Pregnant Women for Preventing Gestational Diabetes Mellitus, Dietary Advice in Pregnancy for Preventing Gestational Diabetes Mellitus, Gestational Weight Gain below Instead of Within the Guidelines Per Class of Maternal Obesity: Obstetrical and Neonatal Outcomes

  • The significance of a healthy diet, physical activity and weight management for the health of the mother herself, the baby and the family should be discussed at the maternal health centre, with practical support provided.
  • If folic acid supplementation (minimum 400 µg/day) was not started when planning pregnancy, it should be started as soon as pregnancy is confirmed and continued until week 12 of pregnancy.
    • If BMI is HASH(0x2f82cc8) 30 kg/m2 , higher doses of folic acid (1-4 mg) can be used based on medical consideration if, for example, the woman has diabetes or an intestinal disease or is on medication increasing the need for folic acid.
  • If the treatment for obesity was not started before pregnancy, lifestyle guidance should be started no later than in early pregnancy. Lifestyle guidance during pregnancy will help to restrict weight gain (see also http://pubmed.ncbi.nlm.nih.gov/28724518/ and http://pubmed.ncbi.nlm.nih.gov/30230252/).
    • See also local recommendations concerning weight loss, weight management, physical activity and nutrition during pregnancy.
  • Recommended weight gain during pregnancy:
    • For overweight women (BMI 25-29.9 kg/m2 ) 7-11 kg
    • For obese women (BMI HASH(0x2f82cc8) 30 kg/m2 ) 5-9 kg.
  • Higher than recommended weight gain is associated with increased risk of fetal macrosomia, caesarean section, and complications associated with blood pressure, as well as of overweight after pregnancy.
  • Lower than recommended weight gain may predispose to low fetal weight and premature delivery but evidence for this is partly contradictory. In obese women (BMI HASH(0x2f82cc8) 30 kg/m2 ), lower than recommended weight gain does not necessarily involve such risks and, indeed, lower weight gain may reduce the risk of fetal macrosomia, caesarean section, pre-eclampsia and overweight after pregnancy Gestational Weight Gain below Instead of Within the Guidelines Per Class of Maternal Obesity: Obstetrical and Neonatal Outcomes.
  • Prophylactic aspirin to prevent pre-eclampsia should be started if other risk factors for pre-eclampsia are detected in addition to obesity (BMI HASH(0x2f82cc8) 30 kg/m2 ); see Antenatal Clinics: Care and Examinations.
  • A glucose tolerance test should be done in all pregnant women in week 24-28 of pregnancy.
    • For women with BMI HASH(0x2f82cc8) 30 kg/m2 or other risk factors Antenatal Clinics: Care and Examinations, a glucose tolerance test should be done as early as week 12-16 of pregnancy and repeated in week 24-28 if the first test was normal.
  • Pregnant women who have undergone bariatric surgery should be referred as early as early pregnancy for follow-up at the maternity hospital outpatient clinic.

Delivery planning

  • If the body mass index (BMI) before pregnancy or in early pregnancy is HASH(0x2f82cc8) 40 kg/m2 , the woman can visit the maternity hospital around week 37 of pregnancy to plan the delivery, as considered necessary. Consulting an anaesthesiologist can also be considered.
  • When admitted for delivery, the mother should be assessed by an anaesthesiologist to establish sufficient i.v. access and to plan suitable analgesia, for example.

Treatment and follow-up after delivery Risk of a Venous Thromboembolism during the Postpartum Period, Support for Healthy Breastfeeding Mothers with Healthy Term Babies, Hormonal Contraception in Overweight or Obese Women, Maternal Health Advantages of Breastfeeding,

  • The risk of deep vein thrombosis after delivery is increased particularly in overweight and obese women Risk of a Venous Thromboembolism during the Postpartum Period.
    • The need for prevention of venous thromboembolism should be considered at the hospital, taking into account any additional risks related to the course of the delivery (such as caesarean section).
  • Breast-feeding should be encouraged and intensive guidance and support provided for this, as necessary Breastfeeding: Advice and Difficulties.
    • In obese women, lactogenesis may be slower for hormonal reasons and breast-feeding may be more challenging for mechanical reasons (e.g. large breasts).
    • Breast-feeding facilitates weight management and reduces the child's risk of subsequent obesity.
  • At visits to maternal and child health centres and other primary health care, individual transitioning to the healthiest possible diet should be discussed and supported, and the significance and possibilities of physical exercise and weight management should be discussed. The post-delivery check-up is important in this respect.
    • Mobile or internet-based or other home weight loss and weight management methods may be suitable in the situation in life after delivery.
  • In terms of contraception Contraception: Initiation, Choice of Method and Follow-Up, any other factors affecting the choice of contraception should be considered, such as other risk factors associated with obesity or the possibly reduced effectiveness of hormonal contraception in women with a BMI > 35 kg/m2 Hormonal Contraception in Overweight or Obese Women.

References

Evidence Summaries ⬆